Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma
Clinical trial NCT02743429 · UNKNOWN
Trial details
- NCT number
- NCT02743429
- Sponsor
- University Medicine Greifswald
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-27
- Primary completion
- 2023-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.